Regal Assets Analytics

Bill Langbein

Keeping an Eye on ALLO, SYRS, PTGX, AUTL, and IMRA in Light of Biotech Catalysts; Disclosure Updates

By |2020-12-07T11:59:23-05:00December 7th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Updates|Tags: , , , , |

Clinical data findings related to five SanaCurrents catalysts will be [...]

Xenon Pharmaceuticals (XENE) Probability Sentiment

By |2020-12-07T10:42:27-05:00December 6th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Probability Sentiment [...]

SanaCurrents holding BioCryst (BCRX) shares into December 3 PDUFA

By |2020-12-02T10:26:29-05:00December 2nd, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

The FDA will decide on December 3 whether to approve [...]

SanaCurrents closing out Adverum Biotechnologies (ADVM)

By |2020-11-21T11:33:39-05:00November 17th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Adverum Biotechnologies (NASDAQ:ADVM) on Saturday reported positive results from its [...]

SanaCurrents Pivotal Sentiment on Protagonist (PTGX) polycythemia vera phase II trial

By |2020-11-17T10:15:51-05:00November 14th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Probability Sentiment [...]

Adverum catalyst set for Saturday, November 14

By |2020-11-17T10:16:00-05:00November 11th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Adverum Biotechnologies (NASDAQ:ADVM) said it will present additional clinical data [...]

Calliditas’ Shares Soar About 35% After Hitting Catalyst

By |2020-11-09T12:00:46-05:00November 9th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Sweden-based Calliditas Therapeutics’ (NASDAQ:CALT) delivered on its phase III trial [...]

SanaCurrents Advantageous Sentiment on Alimera Sciences, Inc. (ALIM) Revenue Growth

By |2020-11-09T09:33:07-05:00November 7th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

Alimera Sciences, Inc. (NASDAQ:ALIM) Probability Sentiment [...]

Go to Top